BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 36728830)

  • 1. Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma.
    Takayama R; Nakagawa H; Sawaki A; Mizuno N; Kawai H; Tajika M; Yatabe Y; Matsuo K; Uehara R; Ono K; Nakamura Y; Yamao K
    J Gastroenterol; 2010; 45(1):52-9. PubMed ID: 19789838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis.
    Debernardi S; Blyuss O; Rycyk D; Srivastava K; Jeon CY; Cai H; Cai Q; Shu XO; Crnogorac-Jurcevic T
    Int J Cancer; 2023 Feb; 152(4):769-780. PubMed ID: 36093581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rigorous Multi-Laboratory Study of Known PDAC Biomarkers Identifies Increased Sensitivity and Specificity Over CA19-9 Alone.
    Haab B; Qian L; Staal B; Jain M; Fahrmann J; Worthington C; Prosser D; Velokokhatnaya L; Lopez C; Tang R; Hurd MW; Natarajan G; Kumar S; Smith L; Hanash S; Batra SK; Maitra A; Lokshin A; Huang Y; Brand RE
    bioRxiv; 2024 May; ():. PubMed ID: 38826212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the potential benefits of early detection for pancreatic cancer through a counterfactual simulation modeling analysis.
    Park J; Lim F; Prest M; Ferris JS; Aziz Z; Agyekum A; Wagner S; Gulati R; Hur C
    Sci Rep; 2023 Nov; 13(1):20028. PubMed ID: 37973858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer.
    Marin AM; Batista M; Korte de Azevedo AL; Bombardelli Gomig TH; Soares Caldeira Brant R; Chammas R; Uno M; Dias Araújo D; Zanette DL; Nóbrega Aoki M
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool?
    Tarasiuk A; Mackiewicz T; Małecka-Panas E; Fichna J
    Cancer Biol Ther; 2021 Jun; 22(5-6):347-356. PubMed ID: 34224317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells.
    Furuta T; Oda T; Kiyoi K; Yusuke O; Kimura S; Kurimori K; Miyazaki Y; Yu Y; Furuya K; Akashi Y; Shimomura O; Tateno H
    Cancer Sci; 2021 Sep; 112(9):3722-3731. PubMed ID: 34115906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.
    McDowell CT; Klamer Z; Hall J; West CA; Wisniewski L; Powers TW; Angel PM; Mehta AS; Lewin DN; Haab BB; Drake RR
    Mol Cell Proteomics; 2021; 20():100012. PubMed ID: 33581409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer.
    Dong D; Jia L; Zhang L; Ma N; Zhang A; Zhou Y; Ren L
    Cancer Sci; 2018 Sep; 109(9):2841-2851. PubMed ID: 29945294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.
    Kim J; Bamlet WR; Oberg AL; Chaffee KG; Donahue G; Cao XJ; Chari S; Garcia BA; Petersen GM; Zaret KS
    Sci Transl Med; 2017 Jul; 9(398):. PubMed ID: 28701476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Circulating Panel of circRNA Biomarkers for the Noninvasive and Early Detection of Pancreatic Ductal Adenocarcinoma.
    Xu C; Jun E; Okugawa Y; Toiyama Y; Borazanci E; Bolton J; Taketomi A; Kim SC; Shang D; Von Hoff D; Zhang G; Goel A
    Gastroenterology; 2024 Jan; 166(1):178-190.e16. PubMed ID: 37839499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma.
    Mawaribuchi S; Shimomura O; Oda T; Hiemori K; Shimizu K; Yamase K; Date M; Tateno H
    Glycobiology; 2023 May; 33(4):342-352. PubMed ID: 36728830
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.